首页 工具
登录
购物车

搜索结果

Search Results for " c-kit "
Targets Recommended: c-Kit c-Kit

131

抑制剂 & 化合物

9

TargetMol 试剂盒

22

重组蛋白

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Form Specificity Of Inhibition
CL0075 c-Kit inhibitor kit

c-Kit inhibitor kit

CL0147 c-FMS inhibitor kit

c-FMS inhibitor kit

CL0089 c-Met/HGFR inhibitor kit

c-Met/HGFR inhibitor kit

CEKY-0003 Human Cystatin C/CST3 ELISA Kit

Human Cystatin C/CST3 ELISA 试剂盒

CL0109 Ras inhibitor kit

Ras inhibitor kit

CL0139 ROS inhibitor kit

ROS inhibitor kit

CL0146 JNK inhibitor kit

JNK inhibitor kit

CL0112 PKC inhibitor kit

PKC inhibitor kit

CL0141 Notch pathway inhibitor kit

Notch pathway inhibitor kit

TargetMol 试剂盒

c-Kit inhibitor kit
Cat.No: CL0075
c-FMS inhibitor kit
Cat.No: CL0147
c-Met/HGFR inhibitor kit
Cat.No: CL0089
Human Cystatin C/CST3 ELISA 试剂盒
Cat.No: CEKY-0003
Ras inhibitor kit
Cat.No: CL0109
ROS inhibitor kit
Cat.No: CL0139
JNK inhibitor kit
Cat.No: CL0146
PKC inhibitor kit
Cat.No: CL0112
Notch pathway inhibitor kit
Cat.No: CL0141
Cat. No. Product Name Target Signaling Pathways
T10651 c-Kit-IN-3

c-Kit Tyrosine Kinase/Adaptors
c-Kit-IN-3 是 c-KIT 激酶的特异性抑制剂,对 c-Kit (wt) 和 c-Kit (T670I) 的 IC50 分别为 4 nM、8 nM。
T4332 c-Kit-IN-1

PDGFR inhibitor 1,DCC-2618

c-Met/HGFR; c-Kit Tyrosine Kinase/Adaptors
c-Kit-IN-1 (DCC-2618) 是c-Kitc-Met 抑制剂(IC50<200 nM)。
T10650 c-Kit-IN-2

c-Kit Tyrosine Kinase/Adaptors
c-Kit-IN-2 is a c-KIT inhibitor (IC50: 82 nM), shows superior antiproliferative activities against all the three GIST cell lines, GIST430, GIST882, and GIST48 (GI50s: 1, 3, and 2 nM).
T19222 c-Kit-IN-3 maleate

Others Others
c-Kit-IN-3 maleate is a potent and selective c-KIT kinase inhibitor (IC50s: 4 nM, 8 nM for c-KIT wt, and c-KIT T670I).
T19220 c-Kit-IN-3 hydrochloride

Others Others
c-Kit-IN-3 hydrochloride is a potent and selective c-KIT kinase inhibitor (IC50s: 4 nM, 8 nM for c-KIT wt, and c-KIT T670I).
T19223 c-Kit-IN-3 tartrate

Others Others
c-Kit-IN-3 tartrate is a potent and selective c-KIT kinase inhibitor (IC50s: 4 nM, 8 nM for c-KIT wt, and c-KIT T670I).
T19221 c-Kit-IN-3 L-tartrate

Others Others
c-Kit-IN-3 L-tartrate is a potent and selective c-KIT kinase inhibitor (IC50s: 4 nM, 8 nM for c-KIT wt, and c-KIT T670I).
T19219 c-Kit-IN-3 D-tartrate

Others Others
c-Kit-IN-3 D-tartrate is a potent and selective c-KIT kinase inhibitor (IC50s: 4 nM, 8 nM for c-KIT wt, and c-KIT T670I).
T3452 ISCK03

c-Kit Tyrosine Kinase/Adaptors
ISCK03 是一种特异性的 SCF/c-Kit 抑制剂。
T5409 AZD3229

c-Kit Tyrosine Kinase/Adaptors
AZD3229 是一种突变型酪氨酸激酶受体抑制剂,可用于胃肠道间质瘤的研究。
T41003 KG5

Raf; FLT; PDGFR; c-Kit Angiogenesis; MAPK; Tyrosine Kinase/Adaptors
KG5 是 PDGFRβ 和 B-Raf 的双重变构抑制剂,对 PDGFRβ 和 PDGFRα 的 Kd 分别为 520 nM 和 300 nM。 KG5 抑制 FLT3、KITc-Raf,具有抗癌和抗血管生成活性。
T22349 JNJ-38158471

CS-2660

VEGFR; c-RET; c-Kit Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors
JNJ-38158471 (CS-2660) 是一种耐受性好的,有口服活性的、高效的、选择性的 VEGFR-2抑制剂 (IC50:40 nM),还能抑制 Ret (IC50:180 nM) 和 Kit (IC50:500 nM)。
T9689 M4205

c-Kit Tyrosine Kinase/Adaptors
M4205 是一种 c-Kit 抑制剂,对外显子 11、13、17 中的 c-Kit 突变具有高活性。
T10652 Vimseltinib

DCC-3014

c-Fms; CSF-1R; c-Kit Tyrosine Kinase/Adaptors
Vimseltinib (DCC-3014) 是 c-FMS(CSF-IR) 和 c-Kit 抑制剂,IC50值分别为 <0.01 μM 和 0.1-1 μM。
T2115 Pexidartinib

PLX-3397

Apoptosis; c-Fms; FLT; CSF-1R; c-Kit Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors
Pexidartinib (PLX-3397) 是具有口服活性的选择性ATP-竞争性的集落刺激因子 1 和c-Kit 抑制剂,IC50值分别为 20 和 10 nM。它可诱导细胞凋亡,具有抗肿瘤活性。
T22256 c-Kit-IN-5-1

3-(2-Aminoquinazolin-6-yl)-4-methyl-1-(4-(oxazol-2-yl)phenyl)pyridin-2(1H)-one,AMG-25,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[4-(1,3-oxazol-2-yl)phenyl]pyridin-2-one

c-Kit Tyrosine Kinase/Adaptors
c-Kit-IN-5-1 (AMG-25) 是一种新型的、高效的、选择性的 c-Kit 抑制剂。
T4320 Flumatinib

HHGV678

Bcr-Abl; PDGFR; c-Kit Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors
Flumatinib (HHGV678) 是一种具有口服活性的选择性 Bcr-Abl 抑制剂,能够作用于 c-Abl (IC50:1.2 nM),PDGFRβ (IC50:307.6 nM) 和 c-Kit (IC50:665.5 nM)。
T5109 Avapritinib

BLU-285

PDGFR; c-Kit Angiogenesis; Tyrosine Kinase/Adaptors
Avapritinib (BLU-285) 是选择性的、高效的、具有口服活性的 KIT 和 PDGFRA 激活环突变激酶抑制剂,能够作用于 KIT D816V (IC50:0.27 nM) 和 PDGFRA D842V (IC50:0.24 nM)。它减弱 ABCB1 和 ABCG2 的传输功能。它与激酶的活性构象结合,并显示抗肿瘤活性。
T7945 SU14813

VEGFR; PDGFR; c-Kit Angiogenesis; Tyrosine Kinase/Adaptors
SU14813 是一种多靶点受体酪氨酸激酶抑制剂,能够抑制 VEGFR2 (IC50:50 nM),VEGFR1 (IC50:2 nM),PDGFRβ (IC50:4 nM),KIT (IC50:15 nM)。
T6166 Telatinib

Bay 57-9352,替拉替尼

VEGFR; PDGFR; c-Kit Angiogenesis; Tyrosine Kinase/Adaptors
Telatinib (Bay 57-9352) 是一种口服具有活力的,小分子的 VEGFR2,VEGFR3,PDGFα 和 c-Kit 抑制剂,它们的 IC50 值分别为6,4,15,1 nM。
T2624 OSI-930

OSI 930,噻尔非尼

Apoptosis; c-Fms; Raf; VEGFR; FLT; CSF-1R; Src; c-Kit Angiogenesis; Apoptosis; MAPK; Tyrosine Kinase/Adaptors
OSI-930 是 Kit,KDR 和 CSF-1R (c-Fms)的口服选择性抑制剂,IC50分别为 80 nM,9 nM 和 15 nM。它具有抗肿瘤活性,靶向肿瘤中的癌细胞增殖和血管生成。它还适度抑制 Flt-1,c-Raf 和 Lck,并且对 PDGFRα/β,Flt-3和 Abl 具有较弱的抑制活性。
TQ0235 AC710

FLT; PDGFR; c-Kit Angiogenesis; Tyrosine Kinase/Adaptors
AC710是一种 PDGFR 抑制剂,能够作用于 FLT3 (Kd:0.6),CSF1R (Kd:1.57),KIT (Kd:1),PDGFRα (Kd:1.3) 和 PDGFRβ (Kd:1.0)。
T2288 Motesanib

AMG 706,莫特塞尼,莫替沙尼

VEGFR; c-Kit Angiogenesis; Tyrosine Kinase/Adaptors
Motesanib (AMG 706) 是有效的、ATP 竞争性的 VEGFR1/2/3 的抑制剂,其IC50值为 2 nM/3 nM/6 nM,与对 Kit 的选择性相似,是 PDGFR 和 Ret 的 10 倍多。
T2288L Motesanib Diphosphate

Motesanib,AMG 706,二磷酸莫替沙尼

VEGFR; c-Kit Angiogenesis; Tyrosine Kinase/Adaptors
Motesanib Diphosphate (AMG 706) 是一种有效的VEGFR1/2/3的 ATP 竞争性抑制剂,IC50值为 2 nM/3 nM/6 nM,与对 Kit 的选择性相似,是 PDGFR 和 Ret 的 10 倍多。
T7861 Flumatinib mesylate

甲磺酸氟马替尼/氟马替尼,HHGV678 mesylate,甲磺酸氟马替尼

Bcr-Abl; PDGFR; c-Kit Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors
Flumatinib mesylate (HHGV678 mesylate) 是一种具有口服活性的选择性Bcr-Abl 抑制剂,能够作用于 c-Abl (IC50:1.2 nM),PDGFRβ (IC50:307.6 nM) 和 c-Kit (IC50:665.5 nM)。
T35570 Chiauranib

CS2164,西奥罗尼

c-Fms; VEGFR; FLT; PDGFR; c-Kit; Aurora Kinase Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Tyrosine Kinase/Adaptors
Chiauranib 是一种针对肿瘤血管生成的多靶点抑制剂,具有强大的抗癌作用。 Chiauranib 有效抑制血管生成相关激酶(VEGFR1、VEGFR2、VEGFR3、PDGFRα 和 c-Kit)、有丝分裂相关激酶 Aurora B 和慢性炎症相关激酶 CSF1R,IC50 值范围为 1-9 nM。
T1836 AZD2932

VEGFR; FLT; PDGFR; c-Kit Angiogenesis; Tyrosine Kinase/Adaptors
AZD2932是一种多靶点激酶抑制剂,细胞试验中能够抑制 VEGFR2 (IC50:8 nM),PDGFβ (IC50:4 nM),PDGFβ (IC50:7 nM) 和 PDGFβ (IC50:9 nM)。
T2516 Amuvatinib

MP470,HPK 56

Apoptosis; FLT; c-Met/HGFR; c-RET; DNA/RNA Synthesis; PDGFR; c-Kit Angiogenesis; Apoptosis; Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Tyrosine Kinase/Adaptors
Amuvatinib (MP470) 是一种多靶点酪氨酸激酶抑制剂,对突变 c-Kit,PDGFRα,Flt3,c-Met 和 c-Ret 具有活性。它还是一种 DNA 修复抑制剂,靶向蛋白 DNA 修复 RAD51,从而破坏 DNA 损伤修复,具有抗肿瘤活性。
T0097L Pazopanib

帕唑帕尼,GW786034

VEGFR; FGFR; PDGFR; c-Kit; Autophagy Angiogenesis; Autophagy; Tyrosine Kinase/Adaptors
Pazopanib (GW786034) 是一种小分子抑制剂,可抑制多种具有潜在抗肿瘤活性的蛋白酪氨酸激酶。它抑制VEGFR1、VEGFR2、VEGFR3、PDGFRβ、c-Kit、FGFR1和c-Fms 的IC50分别为10、30、47、84、74、140和146 nM。
T4191 Multi-kinase inhibitor 1

Multi-kinase inhibitor I

Others; Bcr-Abl; PDGFR; c-Kit Angiogenesis; Cytoskeletal Signaling; Others; Tyrosine Kinase/Adaptors
Multi-kinase inhibitor 1 (Multi-kinase inhibitor I) 是多激酶抑制剂。它有用于导致与酪氨酸激酶活性异常或失控有关的疾病或失调的潜力,特别是与c-Kit,PDGF-R,Bcr-abl 活性相关的疾病。
T13178 Toceranib

托西尼布,PHA 291639E,SU11654

VEGFR; PDGFR; c-Kit Angiogenesis; Tyrosine Kinase/Adaptors
Toceranib (PHA 291639E) 是口服具有活力的受体酪氨酸激酶 (RTK) 抑制剂,能有效抑制PDGFR,VEGFR,Kit,抑制 PDGFRβ 和 Flk-1/KDR 的Ki 分别为 5 nM 和 6 nM。它具有抗肿瘤和抗血管生成作用,用于研究犬肥大细胞肿瘤。
T0520 Lenvatinib

仑伐替尼,E7080

VEGFR; FGFR; c-RET; PDGFR; c-Kit Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors
Lenvatinib (E7080) 是一种多靶点受体酪氨酸激酶抑制剂,抑制 VEGFR1-3、FGFR1-4、KIT、PDGFR 和 RET 等,具有口服活性。Lenvatinib 对 VEGFR2 和 VEGFR3 的抑制活性最强 (IC50=4/5.2 nM)。Lenvatinib 具有强效抗肿瘤活性。
T4349 Sitravatinib

MG516,MGCD516

Discoidin Domain Receptor (DDR); VEGFR; FLT; Trk receptor; TAM Receptor; c-Kit; Ephrin Receptor Angiogenesis; Tyrosine Kinase/Adaptors
Sitravatinib (MGCD516) 是一种有口服活性的受体酪氨酸激酶抑制剂。它单独使用即具有有效的抗肿瘤功效,且通过促进抗肿瘤免疫微环境增强了 PD-1 阻断的活性。
T11641 N-Desmethyl imatinib

Imatinib metabolite N-Desmethyl imatinib,Norimatinib,N-去甲基伊马替尼

Bcr-Abl; PDGFR; c-Kit; Drug Metabolite Angiogenesis; Cytoskeletal Signaling; Metabolism; Tyrosine Kinase/Adaptors
N-Desmethyl imatinib (Imatinib metabolite N-Desmethyl imatinib) 是 Imatinib 的代谢物。Imatinib 是一个靶向 c-Kit、v-Abl 和 PDGFR 的多靶点抑制剂。
T2609 Masitinib

AB1010,马赛替尼

Apoptosis; FAK; c-Fms; FGFR; Bcr-Abl; PDGFR; Src; c-Kit; Hck Angiogenesis; Apoptosis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors
Masitinib (AB1010) 是生物口服可利用的选择性 c-Kit 抑制剂 (对于人重组c-Kit,IC50=200 nM),它还抑制PDGFRα/β(IC50s=540/800 nM),Lyn(对 LynB 的IC50=510 nM),Lck,较小程度上抑制FGFR3和FAK。它有抗增殖,促凋亡活性,且毒性低。
T4315 Ki20227

N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]-2-甲氧基苯基]-N'-[1-(2-噻唑基)乙基]脲

c-Fms; VEGFR; CSF-1R; PDGFR; c-Kit Angiogenesis; Tyrosine Kinase/Adaptors
Ki20227 是一种高效的、口服具有活性的、选择性的CSF1R(c-Fms 酪氨酸激酶)抑制剂,对 CSF1R,VEGFR2,c-Kit 和PDGFRβ的IC50分别为 2 nM,12 nM,451 nM 和 217 nM。它可以阻止破骨细胞分化和溶骨性破坏。
T6230 Imatinib

伊马替尼,STI571,CGP057148B,ST-1571

SARS-CoV; Bcr-Abl; PDGFR; c-Kit; Autophagy Angiogenesis; Autophagy; Cytoskeletal Signaling; Microbiology/Virology; Tyrosine Kinase/Adaptors
Imatinib (STI571) 是一种多靶点受体酪氨酸激酶抑制剂,可选择性抑制 BCR/ABL、v-Abl、PDGFR、c-kit 等激酶活性,具有口服活性。Imatinib 具有抗肿瘤活性,可用于治疗慢性粒细胞白血病。
T8482 Ripretinib

DCC-2618,瑞普替尼

Apoptosis; VEGFR; FLT; PDGFR; c-Kit Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors
Ripretinib (DCC-2618) 是一种口服生物利用的,选择性 KIT 和 PDGFRA 开关控制抑制剂,具有抗肿瘤作用并诱导细胞凋亡。它专门针对 KIT 和 PDGFRA 的野生型和突变型并与之结合在其开关口袋结合位点,从而防止这些激酶从无活性构象转变为有活性构象,并使它们的野生型和突变体形式失活。
T2051 SKLB4771

FLT3-​IN-​1,FLT3-IN-1

FLT Angiogenesis; Tyrosine Kinase/Adaptors
SKLB4771 (FLT3-IN-1) 是一种新型的、高效的 Flt3 抑制剂 (IC50:10nM)。
T2586 Cabozantinib

卡博替尼,XL184,BMS-907351

Apoptosis; VEGFR; FLT; c-Met/HGFR; c-RET; TAM Receptor; c-Kit Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors
Cabozantinib (XL184) 是一种多靶点酪氨酸激酶受体抑制剂,可以抑制 VEGFR2、c-Met、Kit、Axl 和 Flt3 (IC50=0.035/1.3/4.6/7/11.3 nM)。Cabozantinib 具有抗肿瘤和抗血管生成活性。
T4053 AST 487

NVP-AST 487

VEGFR; FLT; c-RET; Bcr-Abl; c-Kit Angiogenesis; Apoptosis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors
AST 487 (NVP-AST 487) 是 RET 激酶抑制剂 (IC50:880 nM),能够抑制 RET 自磷酸化,及下游效应器激活,也抑制 Flt-3 (IC50:520 nM)。
T8544 Masitinib mesylate

甲磺酸马赛替尼,AB-1010 mesylate,马赛替尼

Apoptosis; FAK; FGFR; PDGFR; Src; c-Kit Angiogenesis; Apoptosis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors
Masitinib mesylate (AB-1010 mesylate) 是一种生物口服可利用的选择性 c-Kit 抑制剂,IC50 为 200 nM。它还抑制 PDGFRα/β,IC50值为540/800 nM,对 LynB 的 IC50为510 nM。它的毒性低,有抗增殖和促凋亡活性。
T8541 Lenvatinib mesylate

仑伐替尼甲酸盐,E7080 (mesylate),乐伐替尼

VEGFR; FGFR; c-RET; PDGFR; c-Kit Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors
Lenvatinib mesylate (E7080 (mesylate)) 是一种口服具有活力的,多靶点酪氨酸激酶抑制剂,能够抑制血管内皮生长因子受体(VEGFR1-3),成纤维细胞生长因子受体(FGFR1-4),干细胞因子受体(KIT),血小板衍生生长因子受体(PDGFR),转染期间重排(RET),具有效抗癌作用。
T3211 Midostaurin

米哚妥林,N-Benzoylstaurosporine,PKC412,CGP41231,CGP 41251,苯甲酰基十字孢碱

Others; PKC Chromatin/Epigenetic; Cytoskeletal Signaling; Others
Midostaurin (PKC412) 是一种多靶点蛋白激酶抑制剂,有抗肿瘤活性,对 PKCα/β/γ、Syk、Flk-1、Akt、PKA、c-Kitc-Fgr、c-Src、FLT3、PDFRβ和VEGFR1/2的IC50值范围为 22 到500 nM 之间。
T1621 Imatinib Mesylate

甲磺酸伊马替尼,ST-1571 Mesylate,STI-571,CGP-57148B

Bcr-Abl; PDGFR; c-Kit; Autophagy Angiogenesis; Autophagy; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors
Imatinib Mesylate (STI-571) 是一种酪氨酸激酶受体抑制剂,具有抗肿瘤活性,对 v-Abl、c-Kit 和 PDGFR 的 IC50 分别为 0.6 μM、0.1 μM 和 0.1 μM。
T6930 Pazopanib Hydrochloride

GW786034,Pazopanib HCl,GW786034 HCl,盐酸帕唑帕尼,Votrient HCl,Armala

c-Fms; VEGFR; FGFR; PDGFR; c-Kit; Autophagy Angiogenesis; Autophagy; Tyrosine Kinase/Adaptors
Pazopanib Hydrochloride (Votrient HCl) 是一种多靶点抑制剂,抑制 VEGFR1、VEGFR2、VEGFR3、PDGFRβ、c-Kit、FGFR1和c-Fms 的IC50分别为10、30、47、84、74、140和146 nM。
T6711 Tyrphostin AG1296

Tyrphostin AG 1296,AG 1296

Apoptosis; FGFR; FLT; PDGFR; c-Kit Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors
Tyrphostin AG1296 (Tyrphostin AG 1296) 抑制人PDGF α和β受体以及相关干细胞因子受体的信号传导,是一种选择性血小板衍生生长因子受体抑制剂,IC50值为 0.8 μM。
T5164 Cabozantinib hydrochloride

XL184,Cabozantinib hydrochloride (849217-68-1(free base)),BMS-907351,盐酸卡博替尼

VEGFR; FLT; c-Met/HGFR; TAM Receptor; c-Kit; ROR Angiogenesis; Metabolism; Tyrosine Kinase/Adaptors
Cabozantinib hydrochloride (XL184) 是一种有效的泛酪氨酸激酶抑制剂,可抑制 VEGFR2、c-Met、Kit、Axl 和 Flt4(IC50:0.035、1.3、4.6、7 和 6 nM)。
T1925 PLX647

c-Fms; c-Kit Tyrosine Kinase/Adaptors
PLX647 是具有口服活性的、高效的、特异性的FMS 和KIT 双激酶抑制剂,IC50分别为 28 和 16 nM。它 (1 μM) 在 400 个激酶组中显示出对 FMS 和 KIT 有选择性,但 FLT3 和 KDR 除外 (IC50=91 和 130 nM)。
T7394 Toceranib Phosphate

SU11654 phosphate,PHA 291639 phosphate,托西尼布磷酸盐

VEGFR; Tyrosinase; PDGFR; c-Kit Angiogenesis; Proteases/Proteasome; Tyrosine Kinase/Adaptors
Toceranib Phosphate (SU11654 phosphate) 是有效的、具有口服活性的酪氨酸激酶 (RTK) 受体抑制剂,能抑制PDGFR,VEGFR,Kit,抑制 PDGFRβ 和 Flk-1/KDR 的Ki 分别为 5 nM 和 6 nM。它具有抗肿瘤和抗血管生成作用,可用于研究犬肥大细胞肿瘤。

化合物

c-Kit-IN-3
Cat.No: T10651
Synonym:
Target: c-Kit
c-Kit-IN-1
Cat.No: T4332
Synonym: PDGFR inhibitor 1,DCC-2618
Target: c-Met/HGFR, c-Kit
c-Kit-IN-2
Cat.No: T10650
Synonym:
Target: c-Kit
c-Kit-IN-3 maleate
Cat.No: T19222
Synonym:
Target: Others
c-Kit-IN-3 hydrochloride
Cat.No: T19220
Synonym:
Target: Others
c-Kit-IN-3 tartrate
Cat.No: T19223
Synonym:
Target: Others
c-Kit-IN-3 L-tartrate
Cat.No: T19221
Synonym:
Target: Others
c-Kit-IN-3 D-tartrate
Cat.No: T19219
Synonym:
Target: Others
ISCK03
Cat.No: T3452
Synonym:
Target: c-Kit
AZD3229
Cat.No: T5409
Synonym:
Target: c-Kit
KG5
Cat.No: T41003
Synonym:
Target: Raf, FLT, PDGFR, c-Kit
JNJ-38158471
Cat.No: T22349
Synonym: CS-2660
Target: VEGFR, c-RET, c-Kit
M4205
Cat.No: T9689
Synonym:
Target: c-Kit
Vimseltinib
Cat.No: T10652
Synonym: DCC-3014
Target: c-Fms, CSF-1R, c-Kit
Pexidartinib
Cat.No: T2115
Synonym: PLX-3397
Target: Apoptosis, c-Fms, FLT, CSF-1R, c-Kit
c-Kit-IN-5-1
Cat.No: T22256
Synonym: 3-(2-Aminoquinazolin-6-yl)-4-methyl-1-(4-(oxazol-2-yl)phenyl)pyridin-2(1H)-one,AMG-25,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[4-(1,3-oxazol-2-yl)phenyl]pyridin-2-one
Target: c-Kit
Flumatinib
Cat.No: T4320
Synonym: HHGV678
Target: Bcr-Abl, PDGFR, c-Kit
Avapritinib
Cat.No: T5109
Synonym: BLU-285
Target: PDGFR, c-Kit
SU14813
Cat.No: T7945
Synonym:
Target: VEGFR, PDGFR, c-Kit
Telatinib
Cat.No: T6166
Synonym: Bay 57-9352,替拉替尼
Target: VEGFR, PDGFR, c-Kit
OSI-930
Cat.No: T2624
Synonym: OSI 930,噻尔非尼
Target: Apoptosis, c-Fms, Raf, VEGFR, FLT, CSF-1R, Src, c-Kit
AC710
Cat.No: TQ0235
Synonym:
Target: FLT, PDGFR, c-Kit
Motesanib
Cat.No: T2288
Synonym: AMG 706,莫特塞尼,莫替沙尼
Target: VEGFR, c-Kit
Motesanib Diphosphate
Cat.No: T2288L
Synonym: Motesanib,AMG 706,二磷酸莫替沙尼
Target: VEGFR, c-Kit
Flumatinib mesylate
Cat.No: T7861
Synonym: 甲磺酸氟马替尼/氟马替尼,HHGV678 mesylate,甲磺酸氟马替尼
Target: Bcr-Abl, PDGFR, c-Kit
Chiauranib
Cat.No: T35570
Synonym: CS2164,西奥罗尼
Target: c-Fms, VEGFR, FLT, PDGFR, c-Kit, Aurora Kinase
AZD2932
Cat.No: T1836
Synonym:
Target: VEGFR, FLT, PDGFR, c-Kit
Amuvatinib
Cat.No: T2516
Synonym: MP470,HPK 56
Target: Apoptosis, FLT, c-Met/HGFR, c-RET, DNA/RNA Synthesis, PDGFR, c-Kit
Pazopanib
Cat.No: T0097L
Synonym: 帕唑帕尼,GW786034
Target: VEGFR, FGFR, PDGFR, c-Kit, Autophagy
Multi-kinase inhibitor 1
Cat.No: T4191
Synonym: Multi-kinase inhibitor I
Target: Others, Bcr-Abl, PDGFR, c-Kit
Toceranib
Cat.No: T13178
Synonym: 托西尼布,PHA 291639E,SU11654
Target: VEGFR, PDGFR, c-Kit
Lenvatinib
Cat.No: T0520
Synonym: 仑伐替尼,E7080
Target: VEGFR, FGFR, c-RET, PDGFR, c-Kit
Sitravatinib
Cat.No: T4349
Synonym: MG516,MGCD516
Target: Discoidin Domain Receptor (DDR), VEGFR, FLT, Trk receptor, TAM Receptor, c-Kit, Ephrin Receptor
N-Desmethyl imatinib
Cat.No: T11641
Synonym: Imatinib metabolite N-Desmethyl imatinib,Norimatinib,N-去甲基伊马替尼
Target: Bcr-Abl, PDGFR, c-Kit, Drug Metabolite
Masitinib
Cat.No: T2609
Synonym: AB1010,马赛替尼
Target: Apoptosis, FAK, c-Fms, FGFR, Bcr-Abl, PDGFR, Src, c-Kit, Hck
Ki20227
Cat.No: T4315
Synonym: N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]-2-甲氧基苯基]-N'-[1-(2-噻唑基)乙基]脲
Target: c-Fms, VEGFR, CSF-1R, PDGFR, c-Kit
Imatinib
Cat.No: T6230
Synonym: 伊马替尼,STI571,CGP057148B,ST-1571
Target: SARS-CoV, Bcr-Abl, PDGFR, c-Kit, Autophagy
Ripretinib
Cat.No: T8482
Synonym: DCC-2618,瑞普替尼
Target: Apoptosis, VEGFR, FLT, PDGFR, c-Kit
SKLB4771
Cat.No: T2051
Synonym: FLT3-​IN-​1,FLT3-IN-1
Target: FLT
Cabozantinib
Cat.No: T2586
Synonym: 卡博替尼,XL184,BMS-907351
Target: Apoptosis, VEGFR, FLT, c-Met/HGFR, c-RET, TAM Receptor, c-Kit
AST 487
Cat.No: T4053
Synonym: NVP-AST 487
Target: VEGFR, FLT, c-RET, Bcr-Abl, c-Kit
Masitinib mesylate
Cat.No: T8544
Synonym: 甲磺酸马赛替尼,AB-1010 mesylate,马赛替尼
Target: Apoptosis, FAK, FGFR, PDGFR, Src, c-Kit
Lenvatinib mesylate
Cat.No: T8541
Synonym: 仑伐替尼甲酸盐,E7080 (mesylate),乐伐替尼
Target: VEGFR, FGFR, c-RET, PDGFR, c-Kit
Midostaurin
Cat.No: T3211
Synonym: 米哚妥林,N-Benzoylstaurosporine,PKC412,CGP41231,CGP 41251,苯甲酰基十字孢碱
Target: Others, PKC
Imatinib Mesylate
Cat.No: T1621
Synonym: 甲磺酸伊马替尼,ST-1571 Mesylate,STI-571,CGP-57148B
Target: Bcr-Abl, PDGFR, c-Kit, Autophagy
Pazopanib Hydrochloride
Cat.No: T6930
Synonym: GW786034,Pazopanib HCl,GW786034 HCl,盐酸帕唑帕尼,Votrient HCl,Armala
Target: c-Fms, VEGFR, FGFR, PDGFR, c-Kit, Autophagy
Tyrphostin AG1296
Cat.No: T6711
Synonym: Tyrphostin AG 1296,AG 1296
Target: Apoptosis, FGFR, FLT, PDGFR, c-Kit
Cabozantinib hydrochloride
Cat.No: T5164
Synonym: XL184,Cabozantinib hydrochloride (849217-68-1(free base)),BMS-907351,盐酸卡博替尼
Target: VEGFR, FLT, c-Met/HGFR, TAM Receptor, c-Kit, ROR
PLX647
Cat.No: T1925
Synonym:
Target: c-Fms, c-Kit
Toceranib Phosphate
Cat.No: T7394
Synonym: SU11654 phosphate,PHA 291639 phosphate,托西尼布磷酸盐
Target: VEGFR, Tyrosinase, PDGFR, c-Kit
Cat. No. Product Name Species Expression System
TMPY-04051 c-Kit Protein, Human, Recombinant (hFc)

SCFR,v-kit Hardy-Zuckerman 4 feli...

Human HEK293 Cells
c-Kit Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 82 kDa and the accession number is P10721-2.
TMPY-01935 c-Kit Protein, Human, Recombinant (His)

PBT,CD117,v-kit Hardy-Zuckerman 4...

Human HEK293 Cells
c-Kit Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 56.7 kDa and the accession number is P10721-2.
TMPY-01802 c-Kit Protein, Mouse, Recombinant (His)

SCO5,SCO1,Bs,Gsfsco1,v-kit

Mouse HEK293 Cells
c-Kit Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 57 kDa and the accession number is P05532-1.
TMPJ-01470 SCF Protein, Human, Recombinant

Mast Cell Growth Factor,c-Kit...

Human E. coli
Stem Cell Factor (SCF) is a hematopoietic growth factor that exerts its activity at the early stages of hematopoiesis. SCF stimulates the proliferation of myeloid, erythroid, and lymphoid progenitors in bone marrow cultures and has been shown to act synergistically with colony stimulating factors.
TMPY-02170 SCF Protein, Human, Recombinant (aa 1-189, His)

DCUA,Kitl,FPHH,SCF,KL-1,SF,FPH2,M...

Human Baculovirus Insect Cells
SCF Protein, Human, Recombinant (aa 1-189, His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 19.9 kDa and the accession number is P21583-1.
TMPY-01801 c-Kit Protein, Mouse, Recombinant (hFc)

SCO1,Gsfsco1,W,v-kit Hardy-Zu...

Mouse HEK293 Cells
c-Kit Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 82.5 kDa and the accession number is P05532-1.
TMPY-06656 c-Kit Protein, Human, Recombinant (His & Avi), Biotinylated

CD117,SCFR,C-Kit,v-k...

Human HEK293 Cells
c-Kit Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 58.50 kDa and the accession number is P10721-2.
TMPY-03567 c-Kit Protein, Human, Recombinant (aa 50-190, His)

SCFR,PBT,C-Kit,CD117,v-<...

Human E. coli
c-Kit Protein, Human, Recombinant (aa 50-190, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 17.9 kDa and the accession number is P10721-1.
TMPY-05655 c-Kit Protein, Rhesus, Recombinant (hFc)

v-kit Hardy-Zuckerman 4 feline sarc

Rhesus HEK293 Cells
c-Kit Protein, Rhesus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 82.3 kDa and the accession number is A0A8J8YKB5.
TMPY-04564 c-Kit Protein, Human, Recombinant (aa 540-972, His & GST)

C-Kit,PBT,SCFR,CD117,v-<...

Human Baculovirus Insect Cells
c-Kit Protein, Human, Recombinant (aa 540-972, His & GST) is expressed in Baculovirus insect cells with His and GST tag. The predicted molecular weight is 76.8 kDa and the accession number is P10721-2.
TMPK-00777 CD117 Protein, Mouse, Recombinant (His)

ckit,PBT,SCFR,KIT,C<...

Mouse HEK293 Cells
The c-kit proto-oncogen (CD 117) has been shown to be present in several cell types including normal and neoplastic hemopoietic cells. Among normal BM cells, CD117 expression has been found in about half of the CD34 precursors including progenitors committed to the erythroid, granulo-monocytic, and megakaryocytic cell lineages. CD117 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 56.63 kDa and the accession number is P05...
TMPK-01270 CD117 Protein, Cynomolgus/Rhesus macaque, Recombinant (His)

KIT,PBT,c-kit,CD117,S

Cynomolgus,Rhesus HEK293 Cells
The c-kit proto-oncogen (CD117) has been shown to be present in several cell types including normal and neoplastic hemopoietic cells. Among normal BM cells, CD117 expression has been found in about half of the CD34 precursors including progenitors committed to the erythroid, granulo-monocytic, and megakaryocytic cell lineages.
TMPJ-00402 CD117 Protein, Human, Recombinant (hFc)

KIT,CD117,v-kit Hardy-Zuc

Human HEK293 Cells
C-Kit/SCF R is a type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem cell factor). c-Kit contains 5 Ig-like C2-type (immunoglobulin-like) domains and 1 protein kinase domain. It belongs to the protein kinase superfamily and CSF-1/PDGF receptor subfamily. SCF R expression on mast cells enables them to infiltrate SCF-secreting tumors where they promote tumor growth and induce local immune suppression. SCF R is up-regulated on dendritic cells by Th2-orTh17-biasing sti...
TMPK-00805 CD117 Protein, Human, Recombinant (His & Avi), Biotinylated

CD117,EC 2.7.10,EC 2.7.10.1,c...

Human HEK293 Cells
The c-kit proto-oncogen (CD 117) has been shown to be present in several cell types including normal and neoplastic hemopoietic cells. Among normal BM cells, CD117 expression has been found in about half of the CD34 precursors including progenitors committed to the erythroid, granulo-monocytic, and megakaryocytic cell lineages. CD117 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 58.60 kDa and the...
TMPY-03136 c-Kit Protein, Rat, Recombinant (His)

v-kit Hardy-Zuckerman 4 feline sarc

Rat HEK293 Cells
c-Kit Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 56.9 kDa and the accession number is Q63116.
TMPY-06652 c-Kit Protein, Rhesus, Recombinant (His)

v-kit Hardy-Zuckerman 4 feline sarc

Rhesus HEK293 Cells
c-Kit Protein, Rhesus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 57 kDa and the accession number is NP_001253024.1.
TMPY-03034 c-Kit Protein, Rat, Recombinant (hFc)

v-kit Hardy-Zuckerman 4 feline sarc

Rat HEK293 Cells
c-Kit Protein, Rat, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 82.4 kDa and the accession number is Q63116.
TMPY-03968 Secretogranin II Protein, Human, Recombinant (His)

EM66,SgII,SN,CHGC,secretogranin I...

Human HEK293 Cells
Kit ligand, also known as Hematopoietic growth factor KL, Mast cell growth factor, Steel factor, Stem cell factor, c-Kit ligand, Kitlg and KITL, is a single-pass type I membrane protein that belongs to the SCF family. KITL / kit ligand also belongs to the family of dimeric transmembrane growth factors. The soluble form of KIT ligand is a secreted protein. Mast cells are thought to participate in a variety of immune responses, such as parasite resistance and the allergic reaction. Mast cell devel...
TMPJ-00895 SCF Protein, Rat, Recombinant (HEK293, His)

steel factor,Mast cell growth fac...

Rat HEK293 Cells
SCF/C-kit ligand is the ligand of the tyrosine-kinase receptor encoded by the KIT locus. Plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. KITLG/SCF binding can activate several signaling pathways. Promotes phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and subsequent activation of the kinase AKT1. In phase I/II...
TMPK-01450 HLA-C*03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His & Avi), Biotinylated

KRAS1,MHC,K-RAS4B,KRAS,CFC2,K-RAS...

Human HEK293 Cells
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01456 HLA-C*03:04&B2M&KRAS G12D (GADGVGKSAL) Tetramer Protein, Human, MHC (His & Avi)

KRAS2,NS,MHC,C-K-RAS,KRAS1,K-RAS2A,K-RAS2B...

Human HEK293 Cells
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.
TMPK-01451 HLA-C 03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His & Avi)

NS3,K-RAS4A,K-Ras 2,NS,KRAS1,RASK2,MHC,KI-RAS,KRAS,...

Human HEK293 Cells
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail.

重组蛋白

c-Kit Protein, Human, Recombinant (hFc)
Cat.No: TMPY-04051
Species: Human
Expression System: HEK293 Cells
c-Kit Protein, Human, Recombinant (His)
Cat.No: TMPY-01935
Species: Human
Expression System: HEK293 Cells
c-Kit Protein, Mouse, Recombinant (His)
Cat.No: TMPY-01802
Species: Mouse
Expression System: HEK293 Cells
SCF Protein, Human, Recombinant
Cat.No: TMPJ-01470
Species: Human
Expression System: E. coli
SCF Protein, Human, Recombinant (aa 1-189, His)
Cat.No: TMPY-02170
Species: Human
Expression System: Baculovirus Insect Cells
c-Kit Protein, Mouse, Recombinant (hFc)
Cat.No: TMPY-01801
Species: Mouse
Expression System: HEK293 Cells
c-Kit Protein, Human, Recombinant (His & Avi), Biotinylated
Cat.No: TMPY-06656
Species: Human
Expression System: HEK293 Cells
c-Kit Protein, Human, Recombinant (aa 50-190, His)
Cat.No: TMPY-03567
Species: Human
Expression System: E. coli
c-Kit Protein, Rhesus, Recombinant (hFc)
Cat.No: TMPY-05655
Species: Rhesus
Expression System: HEK293 Cells
c-Kit Protein, Human, Recombinant (aa 540-972, His & GST)
Cat.No: TMPY-04564
Species: Human
Expression System: Baculovirus Insect Cells
CD117 Protein, Mouse, Recombinant (His)
Cat.No: TMPK-00777
Species: Mouse
Expression System: HEK293 Cells
CD117 Protein, Cynomolgus/Rhesus macaque, Recombinant (His)
Cat.No: TMPK-01270
Species: Cynomolgus,Rhesus
Expression System: HEK293 Cells
CD117 Protein, Human, Recombinant (hFc)
Cat.No: TMPJ-00402
Species: Human
Expression System: HEK293 Cells
CD117 Protein, Human, Recombinant (His & Avi), Biotinylated
Cat.No: TMPK-00805
Species: Human
Expression System: HEK293 Cells
c-Kit Protein, Rat, Recombinant (His)
Cat.No: TMPY-03136
Species: Rat
Expression System: HEK293 Cells
c-Kit Protein, Rhesus, Recombinant (His)
Cat.No: TMPY-06652
Species: Rhesus
Expression System: HEK293 Cells
c-Kit Protein, Rat, Recombinant (hFc)
Cat.No: TMPY-03034
Species: Rat
Expression System: HEK293 Cells
Secretogranin II Protein, Human, Recombinant (His)
Cat.No: TMPY-03968
Species: Human
Expression System: HEK293 Cells
SCF Protein, Rat, Recombinant (HEK293, His)
Cat.No: TMPJ-00895
Species: Rat
Expression System: HEK293 Cells
HLA-C*03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His & Avi), Biotinylated
Cat.No: TMPK-01450
Species: Human
Expression System: HEK293 Cells
HLA-C*03:04&B2M&KRAS G12D (GADGVGKSAL) Tetramer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01456
Species: Human
Expression System: HEK293 Cells
HLA-C 03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His & Avi)
Cat.No: TMPK-01451
Species: Human
Expression System: HEK293 Cells
共131条,每页50条 1 2 3
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼